Latest news
Loading news…
Averna Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Boston, Massachusetts, United States Founded 2022 11-50 employees For Profit
Averna Therapeutics develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
0
1 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 12
- Patents granted
- 0
- Trademarks
- 1
- IT spend
- $247K
Company Info
- Founded
- 2022
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 17
- HQ
- Boston, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 0.3
- Trend (30d)
- -0.7
- Trend (90d)
- -2.7
- Last leadership hire
- Mar 26, 2026
Key People at Averna Therapeutics
CEO
Chief Scientific Officer
Chief Financial Officer
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Averna Therapeutics
Loading news…
FAQs about Averna Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.